Wall Street analyst estimates for Quanterix Corporation (QTRX): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
Quanterix Corporation, based in Billerica, Massachusetts, is a life sciences enterprise dedicated to pioneering and commercializing advanced digital immunoassay platforms. These sophisticated systems are designed to enhance precision health in both scientific research and diagnostic applications, reaching markets across North America, Europe, the Middle East, Africa, and the Asia Pacific regions.
Analyst Consensus
| Strong Buy | 0 |
| Buy | 5 |
| Hold | 5 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 10 |
| Avg rating (1-5) | 0.50 |
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2026-11-09 | $-0.43 | ||
| 2026-08-10 | $-1.04 | $-0.41 | -153.5% |
| 2026-05-06 | $-0.39 | $-0.31 | -25.8% |
| 2026-03-02 | $-0.38 | $-0.27 | -40.7% |
| 2025-11-10 | $-0.73 | $-0.23 | -217.4% |
| 2025-08-07 | $-0.77 | $-0.41 | -87.8% |
| 2025-05-12 | $-0.53 | $-0.69 | +23.2% |
| 2025-03-17 | $-0.30 | $-0.27 | -11.1% |
Valuation Ratios
| Price / Book | 0.59 |
| EV / EBITDA | -1.00 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $17.6M | $22.9M | $37.6M | $56.7M | $86.4M | $110.6M | $105.5M | $121.1M | $135.4M | $138.7M |
| Cost of Revenue | $9.8M | $12.9M | $19.6M | $29.9M | $38.2M | $45.8M | $60.2M | $48.1M | $54.3M | $73.9M |
| Gross Profit | $7.7M | $10.0M | $18.0M | $26.8M | $48.2M | $64.8M | $45.4M | $73.0M | $81.1M | $64.7M |
| Research & Development | $17.0M | $16.3M | $15.3M | $16.2M | $20.2M | $28.4M | $26.8M | $26.1M | $31.1M | $35.9M |
| Selling, General & Admin | $12.5M | $19.7M | $33.8M | $52.2M | $59.6M | $92.9M | $91.9M | $92.8M | $104.6M | $138.9M |
| Operating Expenses | $29.5M | $36.0M | $49.1M | $68.4M | $79.8M | $121.3M | $149.6M | $119.0M | $133.7M | $174.5M |
| Operating Income | -$21.7M | -$26.0M | -$31.6M | -$41.6M | -$31.6M | -$56.5M | -$104.3M | -$46.0M | -$52.6M | -$109.8M |
| EBITDA | -$21.4M | -$25.6M | -$30.2M | -$38.6M | -$27.3M | -$50.3M | -$67.9M | -$36.4M | -$29.7M | -$93.3M |
| Interest Expense | $1.3M | $952000 | 0 | 0 | $273000 | $403000 | 0 | 0 | 0 | 0 |
| Pre-tax Income | -$23.2M | -$27.0M | -$31.0M | -$41.0M | -$31.9M | -$55.6M | -$99.4M | -$27.6M | -$38.1M | -$112.3M |
| Income Tax | 0 | 0 | $25000 | -$187000 | -$376000 | -$36000 | $164000 | $719000 | $434000 | -$5.1M |
| Net Income | -$23.2M | -$27.0M | -$31.0M | -$40.8M | -$31.5M | -$55.5M | -$99.6M | -$28.4M | -$38.5M | -$107.2M |
| EPS | $-1.43 | $-1.24 | $-1.41 | $-1.63 | $-1.07 | $-1.60 | $-2.61 | $-0.86 | $-1.00 | $-2.51 |
| EPS (Diluted) | $-1.43 | $-1.24 | $-1.39 | $-1.63 | $-1.07 | $-1.60 | $-2.61 | $-0.86 | $-1.00 | $-2.51 |
| Shares Outstanding (Diluted) | $16.2M | $21.7M | $22.4M | $25.1M | $29.6M | $36.0M | $37.0M | $37.6M | $38.4M | $42.6M |
Price
| Price | $2.91 |
| Market Cap | $137M |
| Exchange | NASDAQ |
| Country | US |
Related companies: CVRX · IMRX · INGN · MASS · NNOX · OM · SENS
Explore sector: Healthcare · Medical - Devices
More sections of QTRX: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks